Patents by Inventor Kaka Dey

Kaka Dey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Condensation curable composition comprising siloxane-imide crosslinker
    Patent number: 11655368
    Abstract: A condensation curable silicone adhesive composition comprising a condensation curable organopolysiloxane, siloxane-imide crosslinker, a condensation catalyst and an additive is shown and described herein. The composition is curable at relatively room temperatures and shows good heat stability.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: May 23, 2023
    Assignee: Momentive Performance Materials Inc.
    Inventors: Subrata Mandal, Tetsuo Fujimoto, Vinodh Rajendra, Debanga B. Konwar, Clarissa Miller, Kaka Dey
  • CONDENSATION CURABLE COMPOSITION COMPRISING SILOXANE-IMIDE CROSSLINKER
    Publication number: 20220195190
    Abstract: A condensation curable silicone adhesive composition comprising a condensation curable organopolysiloxane, siloxane-imide crosslinker, a condensation catalyst and an additive is shown and described herein.
    Type: Application
    Filed: December 23, 2020
    Publication date: June 23, 2022
    Inventors: Subrata Mandal, Tetsuo Fujimoto, Vinodh Rajendra, Debanga B. Konwar, Clarissa Miller, Kaka Dey
  • CCR10 antagonists
    Patent number: 8299123
    Abstract: The invention relates to a compound of formula (I): or a tautomer thereof or a pharmaceutically acceptable salt thereof, wherein R1 to R11, W, X, Y, Z, and n are as defined herein. The invention also relates to methods of using the compounds of formula (I) and compositions thereof to treat various diseases and disorders in a patient. The invention also relates to processes for preparing the compounds of formula (I) and intermediates useful in these processes.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: October 30, 2012
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Kaka Dey, Donghong Amy Gao, Daniel R. Goldberg, Alexander Heim-Riether, John Edward Mangette, Ingo Andreas Mugge, Roger John Snow, Alan David Swinamer, Jiang-Ping Wu, Zhaoming Xiong, Yu Yang
  • CCR10 ANTAGONISTS
    Publication number: 20110039851
    Abstract: The invention relates to a compound of formula (I): or a tautomer thereof or a pharmaceutically acceptable salt thereof, wherein R1 to R11, W, X, Y, Z, and n are as defined herein. The invention also relates to methods of using the compounds of formula (I) and compositions thereof to treat various diseases and disorders in a patient. The invention also relates to processes for preparing the compounds of formula (I) and intermediates useful in these processes.
    Type: Application
    Filed: October 14, 2008
    Publication date: February 17, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Kaka Dey, Donghong Amy Gao, Daniel R. Goldberg, Alexander Heim-Riether, John Edward Mangette, Ingo Andreas Mugge, Roger John Snow, Alan David Swinamer, Jiang-Ping Wu, Zhaoming Xiong, Yu Yang
  • Triaza Compound Immunoregulatory Agents
    Publication number: 20090048222
    Abstract: The invention provides certain macrocyclic triaza compounds which down-regulate CD4 expression for use in the treatment of autoimmune diseases and inflammatory diseases or conditions. In a specific embodiment, the invention provides certain naphthalene substituted triaza macrocycles which exhibit high activity for down regulation of CD4 expression. In particular, triaza macrocycles having dansyl groups are provided for use in pharmaceutical compositions.
    Type: Application
    Filed: October 12, 2007
    Publication date: February 19, 2009
    Inventors: Thomas Bell, Dominique Schols, Kaka Dey, Kurt Vermeire
  • Triaza compound immunoregulatory agents
    Publication number: 20040220164
    Abstract: The invention provides certain macrocyclic triaza compounds which down-regulate CD4 expression for use in the treatment of autoimmune diseases and inflammatory diseases or conditions. In a specific embodiment, the invention provides certain naphthalene substituted triaza macrocycles which exhibit high activity for down regulation of CD4 expression. In particular, triaza macrocycles having dansyl groups are provided for use in pharmaceutical compositions.
    Type: Application
    Filed: October 6, 2003
    Publication date: November 4, 2004
    Inventors: Thomas Bell, Dominique Schols, Kaka Dey, Kurt Vermeire